Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Prevail Therapeutics Inc. (PRVL)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-19Dec-31-18
   10-K10-K
Operating Expenses:    
Research and development  48.814.1
General and administrative  17.04.7
    Operating expenses  -65.8-18.8
Other income  2.6-0.3
Interest income, net  2.60.9
    Net loss  -63.2-19.1
   
Other comprehensive loss    
   
Net loss per share    
Basic and Diluted  ($2.22)($3.71)
   
Weighted average shares outstanding:    
Basic and Diluted  28.55.1

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy